PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and.\', \'Endocrinology Laboratory, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1182/bloodadvances.2021005094
?:doi
?:hasPublicationType
?:journal
  • Blood advances
is ?:pmid of
?:pmid
?:pmid
  • 34387648
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all